Yi Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yi Kong has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Yan Zhang
Medical Genetics Centre, Guangdong Women and Children Hospital, Guangzhou, China
2 shared publications - Aihua Yin
Medical genetic center, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China
1 shared publication Cuize Yao
Medical Genetic Center Guangdong Women and Children Hospital Guangzhou China
1 shared publicationHaiyan Wang
1 shared publicationHaowen Tan
Department of Medical Genetics SynerGene Education, Hejun College Huichang China
1 shared publicationHaoyu Dou
Department of Bioinformatics Aegicare (Shenzhen) Technology Co., Ltd. Shenzhen China
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (9) , e70761
Systematic evaluation of whole exome sequencing for copy number variation detection in prenatal diagnosis
- 8 September 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (9) , e70761
Open AccessSystematic evaluation of whole exome sequencing for copy number variation detection in prenatal diagnosis
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1)
Phenotypes of Hereditary Diseases Associated With Rauch–Steindl Syndrome
Purpose: Prenatal phenotypic manifestations of genetic disorders associated with NSD2 variants remain poorly characterized. This study presents our institutional experience with the prenatal diagnosis of NSD2 ‐associated genetic disorders, specifically Rauch–Steindl syndrome (RAUST), aiming to improve understanding of both the molecular and clinical features of RAUST. Methods: We performed a retrospective analysis of six fetuses and one adult diagnosed with RAUST at our institution and thoroughly reviewed the prenatal ultrasound reports of six fetuses. Prenatal and postnatal phenotypes of RAUST cases were summarized alongside findings from previously published literature. Correlations between NSD2 variant locations, variant types, and phenotypes were analyzed. Additionally, protein modeling was used to visualize structural changes in NSD2 protein before and after C‐terminal variants. We integrated single‐cell transcriptomic and gene expression data from multiple public databases to investigate spatiotemporal expression patterns of NSD2 during human fetal development. Results: Fetal growth restriction (FGR) was the most prevalent prenatal manifestation in RAUST fetuses, followed by microcephaly. Bilateral renal hypoplasia emerged as a novel prenatal ultrasonographic feature. Postnatally, speech and motor developmental delays were the most commonly reported phenotypes, followed by physical developmental delays and intellectual disability. Genotype‐phenotype correlation analysis revealed an association between N‐terminal truncating variants in NSD2 and impaired fetal growth parameters. Notably, C‐terminal truncating variants—predicted not to directly impact NSD2 functional domains—also exerted disease‐causing effects. Conclusion: This study provides a comprehensive analysis of prenatal phenotypes in RAUST cases, enriching the prenatal phenotypic spectrum of the disease and facilitating early diagnosis and clinical management of RAUST. Furthermore, our genotype‐phenotype correlation findings lay a foundational basis for future research into the complex molecular mechanisms underlying NSD2 ‐associated genetic disorders.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1)
Open AccessPhenotypes of Hereditary Diseases Associated With Rauch–Steindl Syndrome
Purpose: Prenatal phenotypic manifestations of genetic disorders associated with NSD2 variants remain poorly characterized. This study presents our institutional experience with the prenatal diagnosis of NSD2 ‐associated genetic disorders, specifically Rauch–Steindl syndrome (RAUST), aiming to improve understanding of both the molecular and clinical features of RAUST. Methods: We performed a retrospective analysis of six fetuses and one adult diagnosed with RAUST at our institution and thoroughly reviewed the prenatal ultrasound reports of six fetuses. Prenatal and postnatal phenotypes of RAUST cases were summarized alongside findings from previously published literature. Correlations between NSD2 variant locations, variant types, and phenotypes were analyzed. Additionally, protein modeling was used to visualize structural changes in NSD2 protein before and after C‐terminal variants. We integrated single‐cell transcriptomic and gene expression data from multiple public databases to investigate spatiotemporal expression patterns of NSD2 during human fetal development. Results: Fetal growth restriction (FGR) was the most prevalent prenatal manifestation in RAUST fetuses, followed by microcephaly. Bilateral renal hypoplasia emerged as a novel prenatal ultrasonographic feature. Postnatally, speech and motor developmental delays were the most commonly reported phenotypes, followed by physical developmental delays and intellectual disability. Genotype‐phenotype correlation analysis revealed an association between N‐terminal truncating variants in NSD2 and impaired fetal growth parameters. Notably, C‐terminal truncating variants—predicted not to directly impact NSD2 functional domains—also exerted disease‐causing effects. Conclusion: This study provides a comprehensive analysis of prenatal phenotypes in RAUST cases, enriching the prenatal phenotypic spectrum of the disease and facilitating early diagnosis and clinical management of RAUST. Furthermore, our genotype‐phenotype correlation findings lay a foundational basis for future research into the complex molecular mechanisms underlying NSD2 ‐associated genetic disorders.